Where will market leadership come from in Samvat 2079? Pankaj Murarka answers
indiatimes.com
economics
2022-10-19 05:00:00

'This is a big moment for Indian pharma because it will transition from doing pure generics drugs to complex generics and novel drugs which are based on significant R&D and brand building which call for significant investments. Indian companies are doing and reaching critical mass in in such a high investment business,' says
Pankaj Murarka, CIO, Renaissance Investment Managers

Samvat 2078 actually saw the leadership coming in and emerging from the FMCG and the auto space. You could say the consumption side was driving the growth.
